Zota Health Care Limited (ZOTA) reports a 67.59% YoY revenue growth in Q1FY27, reaching ₹17,360.23 lakhs, driven by network expansion.
Supriya Lifescience Limited (NSE: SUPRIYA) drops 6% intraday to ₹858.65, showing a breakdown in trendline status in the Healthcare » Biotechnology sector.
Anthem Biosciences Limited (NSE: ANTHEM) stock cleared its 6M resistance trendline and is up 5% intraday at ₹896.8.
Biocon Limited (BIOCON) reports Q1 FY27 results with a 9% revenue increase, driven by strong biosimilars performance.
Biocon Limited (BIOCON) reports a 9% rise in total income to Rs 4,391 Cr for Q1 FY27, driven by strong Biopharma growth.
Blue Jet Healthcare Limited (BLUEJET) has broken below its support line and is down 5% intraday at ₹593.9.
Biocon Limited (BIOCON) announces the U.S. launch of Yesafili™, a biosimilar to Regeneron’s Eylea® 2 mg, expanding access to eye treatment.
